Comparable stake leader
Avery W. Catlin
SEC ownership of Provention Bio, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001695357.
Disclosed value leader
Avery W. Catlin
Comparable rows
0/5
Latest evidence
27 Apr 2023
- Parsed ownership sources
- 3/4/5
- Largest SEC-reported holder
- Avery W. Catlin
- Latest parsed ownership date
- 27 Apr 2023
- Issuer CIK
- 0001695357
- Issuer location
- Red Bank, NJ
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
1 signal
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Provention Bio, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Avery W. Catlin
Disclosed value leader
Avery W. Catlin
Comparable rows
0/5
Latest evidence
27 Apr 2023
3/4/5
Highest disclosed value: $243,200
5 rows are not safely comparable across share classes.
Quick read
Avery W. Catlin has the largest disclosed position value at $243.2K.
0 of 5 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Avery W. Catlin's linked filing trail.
Disclosed position value
Top 1
Avery W. Catlin
$243.2K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-5 of 5 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Avery W. Catlin |
3/4/5
Director
|
—
class O/S missing
|
$243,200
10,000 shares
|
— | 27 Apr 2023 |
| Drechsler Andrew T. |
3/4/5
Chief Financial Officer
|
—
class O/S missing
|
—
139,500 shares
|
— | 12 May 2021 |
| Sarah O'Brien |
3/4/5
Chief People Officer
|
—
class O/S missing
|
—
100,000 shares
|
— | 10 Jan 2023 |
| Jeffrey A. Bluestone |
3/4/5
Director
|
—
class O/S missing
|
—
33,000 shares
|
— | 17 May 2022 |
| Sean M. Doherty |
3/4/5
Director
|
—
class O/S missing
|
—
33,000 shares
|
— | 17 May 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 05 Jun 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-19 of 19 reporting-owner rows connected to Provention Bio, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
19
Largest Forms 3/4/5 holder
Avery W. Catlin
Net 12M change
$0
Latest report
27 Apr 2023
Recent insider transactions for Provention Bio, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||
* marks a reported price that did not pass the local price check.